Xtant Med Hldgs Inc (XTNT) Hedge Fund Ownership (Q2 2026)

Q: Is it too late to buy Xtant Med Hldgs Inc (XTNT) following the 2026 Q2 hedge fund 13F filings?

As of today, XTNT has moved +22.6% since the 2026 Q2 13F filing date (August 14, 2026), compared to +2.3% for the XLV sector ETF — an outperformance of +20.3%. Since the quarter end (June 30, 2026), XTNT gained -9.7% vs +7.9% for XLV. The stock has meaningfully outrun its sector. The trade has partially played out; entry is at a premium to the fund's implied reference.

Xtant Med Hldgs Inc (XTNT)

32 + Investors. Track Smart Money conviction in XTNT. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — XTNT

Based on 34 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q

For 1 consecutive quarter, more hedge funds reduced or closed their XTNT positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

🏔️

At the ownership peak (97% of max)

97% of all-time peak

34 hedge funds hold XTNT right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

🚀

Fast accumulation — +31% more funds vs a year ago

fund count last 6Q

+8 new funds entered over the past year (+31% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.

🟠

More sellers than buyers — 48% buying

12 buying13 selling

Last quarter: 13 funds reduced or exited vs 12 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

⚠️

Fewer new buyers each quarter (-6 vs last Q)

new funds entering per quarter

Funds opening this position for the first time: 7 → 4 → 12 → 6. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.

📌

Mixed — 35% long-term, 35% new

■ 35% conviction (2yr+) ■ 29% medium ■ 35% new

Of the 34 current holders: 12 (35%) held >2 years, 10 held 1–2 years, and 12 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

💎

Buying through price weakness — shares -1%, value -30%

Value

-29%

Last quarter: funds added -1% more shares while total portfolio value only changed -30%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.

➡️

Steady discovery — ~6 new funds/quarter

3 → 7 → 4 → 12 → 6 new funds/Q

New funds entering each quarter: 7 → 4 → 12 → 6. Consistent flow of new institutional buyers without clear acceleration or slowdown.

🏛️

Veteran-anchored — 47% veterans vs 38% newcomers

■ 47% veterans ■ 15% 1-2yr ■ 38% new

Entry-cohort mix of 34 holders: 16 (47%) are 2+ year veterans, 5 entered 1–2 years ago, and 13 (38%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.

📋

Smaller funds dominant — 1% AUM from top-100

1% from top-100 AUM funds

9 of 34 holders rank in the top 100 by AUM, but together hold only 1% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

4.3

out of 10

Moderate Exit Risk

Exit risk score 4.3/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q2)	Prior (2026 Q1)	Change
Funds Holding	32	34	-5.88%
13F Shares	80M	81M	-0.6%
Total Value	$34M	$45M	-25.01%
New Positions	5	6	-1
Increased Positions	6	6	-
Closed Positions	7	7	-
Reduced Positions	3	6	-3
Total Calls	0	0	-
Total Puts	0	0	-
PUT/CALL Ratio	0.0	0.0	Bullish

Metric

All 13F Filers (2026 Q2)

Prior (2026 Q1)

Change

Funds Holding

-5.88%

13F Shares

80M

81M

-0.6%

Total Value

$34M

$45M

-25.01%

New Positions

-1

Increased Positions

Closed Positions

Reduced Positions

-3

Total Calls

Total Puts

PUT/CALL Ratio

0.0

Bullish

Institutional Holders (2026 Q2)

32 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in XTNT. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 XTNT holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Nantahala Capital Management, LLC	0.96%	68,394,000	$28.8M
2	AWM Investment Company, Inc.	0.22%	5,976,910	$2.5M
3	Nano Cap New Millennium Growth Fund L P	0.13%	400,000	$168K
4	Wiregrass Investment Management LLC	0.04%	150,000	$63K
5	Mink Brook Asset Management LLC	0.02%	109,466	$46K
6	Crescent Grove Advisors, LLC	0.01%	412,024	$173K
7	Ground Swell Capital, LLC	0.01%	13,070	$6K
8	Bridgeway Capital Management, LLC	0.00%	164,100	$69K
9	Renaissance Technologies LLC	0.00%	935,119	$394K
10	XTX Topco Ltd	0.00%	68,531	$29K
11	Tower Research Capital LLC (TRC)	0.00%	10,398	$4K
12	Equitable Holdings, Inc.	0.00%	11,450	$5K
13	Kestra Advisory Services, LLC	0.00%	20,000	$8K
14	Vanguard Fiduciary Trust Co	0.00%	257,988	$109K
15	MassMutual Private Wealth & Trust, FSB	0.00%	2,000	—
16	Vanguard Capital Management LLC	0.00%	2,014,603	$848K
17	Hrt Financial LP	0.00%	19,597	$8K
18	Millennium Management LLC	0.00%	84,490	$36K
19	Citadel Advisors LLC	0.00%	191,369	$81K
20	Sei Investments Co	0.00%	24,760	$10K
21	Valley Wealth Managers, INC.	0.00%	298	—
22	Commonwealth Equity Services, LLC	0.00%	12,691	$5K
23	UBS Group AG	0.00%	31,920	$13K
24	BlackRock, Inc.	0.00%	115,782	$49K
25	Wells Fargo & Company/Mn	0.00%	488	—

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Xtant Med Hldgs Inc (XTNT)

What does the Smart Money Trend signal show for XTNT?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their XTNT positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for XTNT?

More sellers than buyers — 48% buying: Last quarter: 13 funds reduced or exited vs 12 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for XTNT holders?

Smaller funds dominant — 1% AUM from top-100: 9 of 34 holders rank in the top 100 by AUM, but together hold only 1% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held XTNT?

Mixed — 35% long-term, 35% new: Of the 34 current holders: 12 (35%) held >2 years, 10 held 1–2 years, and 12 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy Xtant Med Hldgs Inc (XTNT) following the 2026 Q2 hedge fund 13F filings?

As of today, XTNT has moved +22.6% since the 2026 Q2 13F filing date (August 14, 2026), compared to +2.3% for the XLV sector ETF — an outperformance of +20.3%. Since the quarter end (June 30, 2026), XTNT has gained -9.7% vs +7.9% for XLV. The stock has meaningfully outrun its sector. The trade has partially played out; entry is at a premium to the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Xtant Med Hldgs Inc (XTNT)

Smart Money Signals — XTNT

Selling streak — 1 quarter in a row

At the ownership peak (97% of max)

Fast accumulation — +31% more funds vs a year ago

More sellers than buyers — 48% buying

Fewer new buyers each quarter (-6 vs last Q)

Mixed — 35% long-term, 35% new

Buying through price weakness — shares -1%, value -30%

Steady discovery — ~6 new funds/quarter

Veteran-anchored — 47% veterans vs 38% newcomers

Smaller funds dominant — 1% AUM from top-100

Institutional Sentiment Summary — XTNT

Hedge Fund Ownership: XTNT

Market Analysis: XTNT

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: XTNT

Is It Too Late to Buy Xtant Med Hldgs Inc (XTNT) Based on Hedge Fund 13F Filings?

Hedge Fund Positioning: XTNT

Statistics: XTNT

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Xtant Med Hldgs Inc (XTNT)

Welcome to 13Foresight!